Here is the latest update from Cardiff Council, covering: the latest workforce position; Cardiff's COVID-19 case and test numbers; cases reported in Cardiff's schools in the last seven days; and vaccination totals for Cardiff and Vale of Glamorgan.

Latest workforce position

We are starting to see increasing levels of staff absences due to the Omicron coronavirus variant and pressures on our workforce, particularly in social care, are continuing to increase. Services are continuing to be delivered effectively, with frontline staff working above and beyond to get the job done.

The modelling suggests that the current wave will peak at around the middle of the month, so we have stringent business continuity plans in place to try to mitigate against that having a serious effect on services, as best we can.

The situation remains under constant review.

Cardiff Cases and Tests - 7 Days Data (27 December 2021 - 02 January 2022)

Based on latest figures from Public Health Wales

Data correct as of:

06 January 2022, 09:00

Cases: 7,879

Cases per 100,000 population: 2,147.4 (Wales: 2,324.6 cases per 100,000 population)

Testing episodes: 15,413

Testing per 100,000 population: 4,200.8

Positive proportion: 51.1% (Wales: 51.2% positive proportion)

COVID-19 Cases reported in Cardiff's schools in the last 7 days (31/12/21 to 06/01/22)

Total number reported = 825

• Pupils and students = 769
• Staff, including teaching staff = 56

Based on latest figures, there are just under 57,000 pupils and students enrolled at Cardiff's schools in total.

Cardiff & Vale University Health Board Vaccination Status Update - 07 January 2022

Data provided by CAVUHB

Based on the figures available at the time of publication.

Please note that there may be minor amendments to data as it is validated over time.

The total number of vaccination doses given by the Cardiff & Vale University Health Board so far, in both local authority areas:1,030,160(1^stDose: 395,510 2^ndDose: 362,834 3^rdDose: 7,669 Boosters: 263,065)

Cohort Data - Last updated: 03 January 2022

• 80 and over: 19,981 / 94.7% (1^stDose) 19,833 / 94% (2^nd& 3^rd*Dose) 18,141 / 91.5% (Booster)
• 75-79: 14,927 / 96.6% (1^stDose) 14,808 / 95.8% (2^nd& 3^rd*Dose) 13,535 / 91.4% (Booster)
• 70-74: 21,396 / 96% (1^stDose) 21,273 / 95.4% (2^nd& 3^rd*Dose) 19,663 / 92.4% (Booster)
• 65-69: 22,016 / 94.5% (1^stDose) 21,783 / 93.5% (2^nd& 3^rd*Dose) 19,838 / 91.1% (Booster)
• 60-64: 26,163 / 92.6% (1^stDose) 25,842 / 91.5% (2^nd& 3^rd*Dose) 23,307 / 90.2% (Booster)
• 55-59: 29,489 / 90.5% (1^stDose) 29,050 / 89.2% (2^nd& 3^rd*Dose) 25,288 / 87% (Booster)
• 50-54: 29,236 / 88.4% (1^stDose) 28,642 / 86.6% (2^nd& 3^rd*Dose) 24,012 / 83.8% (Booster)
• 40-49: 56,002 / 82.3% (1^stDose) 54,340 / 79.9% (2^nd& 3^rd*Dose) 40,419 / 74.4% (Booster)
• 30-39: 62,226 / 76.9% (1^stDose) 58,778 / 72.7% (2^nd& 3^rd*Dose) 31,746 / 58.1% (Booster)
• 18-29: 83,642 / 78.4% (1^stDose) 75,565 / 70.9% (2^nd& 3^rd*Dose) 34,746 / 46% (Booster)
• 16-17: 4,220 / 76.2% (1^stDose) 2,893 / 52.3% (2^nd& 3^rd*Dose) 188 / 6.5% (Booster)
• 12-15: 16,026 / 57.4% (1^stDose) 1,717 / 6.2% (2^nd& 3^rd*Dose)

• Severely Immunosuppressed: 6,786 / 99.3% (1^stDose) 6,013 / 88% (2^nd& 3^rd*Dose) 26 / 0.4% (Booster)
• Care home residents: 2,073 / 98.5% (1^stDose) 2,055 / 97.6% (2^nd& 3^rd*Dose) 1,855 / 90.3% (Booster)
• Care Home Workers: 3,697 / 98.9% (1^stDose) 3,640 / 97.4% (2^nd& 3^rd*Dose) 2,818 / 77.4% (Booster)
• Healthcare Workers: 27,155 / 98.1% (1^stDose) 26,868 / 97.1% (2^nd& 3^rd*Dose) 23,640 / 88% (Booster)
• Social Care Workers**: 7,901 / 79.5% (Booster)
• Clinically extremely vulnerable: 11,209 / 94.7% (1^stDose) 11,043 / 93.3% (2^nd& 3^rd*Dose) 6,268 / 56.8% (Booster)
• Underlying Health Conditions: 46,148 / 90.6% (1^stDose) 44,782 / 87.9% (2^nd& 3^rd*Dose) 36,483 / 81.5% (Booster)
• Underlying Health Conditions (12-15): 646 / 61.7% (1^stDose) 490 / 46.8% (2^nd& 3^rd*Dose) 12 / 2.4% (Booster)

*Those who have received two COVID-19 vaccine doses, with the exception of those who are severely immunosuppressed who are recommended three doses

**Data taken from an alternative source